Textbook of Urgent Care Medicine, Chapter 4, Acute Focal Neurologic Deficit

Published on October 26, 2026

Original author: Joe Toscano

Originally published in 2014. Substantially updated and clinically reviewed in 2026 to reflect current evidence, guidelines, and urgent care practice.

Introduction

Acute focal neurologic deficit is an uncommon presentation in urgent care practice and engenders a broad differential diagnosis procedure.

Because of the need for extremely time-sensitive therapies, it is of paramount importance to quickly identify and rapidly transport patients to an emergency department when such deficit is due to acute stroke.

In addition to stroke, other acute causes of a central nervous system (CNS) intracranial or spinal cord deficit must be distinguished from peripheral nervous system (radicular and peripheral nerve) and other “masquerading” (motor endplate or primary muscular disease) conditions.

Current stroke care extends well beyond the older 3- to 4.5-hour treatment concept. Urgent care clinicians should assume that a new disabling focal deficit may still be treatment-eligible until a stroke-capable receiving team determines otherwise.

Presentation

Acute focal neurologic deficits may include the following, singly or in combination:

Motor weakness
Sensory loss or decreased sensation
Ambulation or other coordination difficulties (ataxia)
Trouble performing complex tasks (apraxia)
Difficulty speaking or understanding language (aphasia, dysphasia)
Trouble swallowing
Bulbar (cranial nerve) deficits
Diplopia and visual field deficits
Vertigo

Triage Pearls

Clinic guidelines should provide for immediate clinician assessment of patients with any symptoms indicative of possible acute stroke.
When clinician assessment suggests acute stroke, in-clinic stabilization and EMS transport to an appropriate stroke-capable emergency department are the priority. Do not delay transport for nonessential laboratory tests, electrocardiography, or imaging that will not change immediate disposition.
Determine and document the exact time the patient was last known well and, when different, the time symptoms were first discovered. Communicate this information directly to EMS and the receiving facility.
Check a fingerstick blood glucose early. Hypoglycemia can mimic a focal neurologic deficit and should be corrected promptly, but persistent focal findings after correction still require stroke evaluation.
IV thrombolysis with tenecteplase or alteplase may be offered to eligible patients within 4.5 hours of symptom onset or last known well. Selected patients with wake-up stroke or presentation 4.5 to 9 hours from last known well may also qualify when advanced imaging demonstrates salvageable tissue.
Endovascular thrombectomy is standard treatment for selected large-vessel occlusion strokes. Eligibility extends to selected anterior-circulation patients up to 24 hours and, in appropriate patients, basilar artery occlusion up to 24 hours.
Transport destination should follow the local stroke system of care. Depending on distance, transfer performance, and local protocols, direct transport to a thrombectomy-capable or comprehensive stroke center may be appropriate.
Assessment of acute neurologic deficit resulting from trauma is often time-sensitive if correction of the neurologic injury is indicated. Rapid assessment and triage is vital in these cases.

Table 1. Immediate Urgent Care Actions for Suspected Stroke or TIA

Action	Urgent care pearl
Recognize	Treat new unilateral weakness/numbness, aphasia, dysarthria, visual loss, neglect, severe ataxia, or brainstem symptoms as possible stroke until proven otherwise.
Time	Document last known well and symptom-discovery time. Do not assume wake-up stroke is outside treatment windows.
Glucose	Obtain point-of-care glucose promptly and correct significant hypoglycemia.
EMS / destination	Activate EMS and prenotify the receiving stroke center. Follow the regional stroke-routing plan rather than defaulting to routine private transport.
Do not delay	Do not keep a suspected stroke patient in urgent care for nonessential testing or observation.
Medication caution	Do not give empiric aspirin or anticoagulation before intracranial hemorrhage has been excluded and the receiving stroke team has determined the treatment pathway.

History and Physical Exam Pearls

Central Nervous System

Most patients with acute-onset focal CNS symptoms will require transfer for further evaluation and treatment, so distinguishing a CNS from a peripheral nervous system process is vital.

The patient’s description of symptoms as well as physical exam findings can usually allow the clinician to “locate the lesion.” Time of symptom onset and a history of trauma preceding the deficit are important.

Associated symptoms such as chest pain, neck pain, and headache can sometimes affect a differential diagnosis as to cause, but the presence and pattern of the neurologic complaints should drive the urgent care evaluation.

Common patterns of CNS neurologic deficit relating to the location of the lesion include the following:

Hemispheric brain
Hemi-face, -limb, or -body weakness and sensory loss contralateral to the brain lesion
Aphasia if the patient’s dominant hemisphere is involved
Visual field deficit contralateral to the brain lesion
Ipsilateral gaze preference
Left sensory neglect if there is nondominant, right-hemispheric involvement
A combination of acute facial paresis, arm drift, and abnormal speech is highly suspicious for a cerebral ischemic process, but absence of this combination does not exclude posterior circulation or other stroke.
Cerebellum involvement is indicated by truncal, gait, or limb ataxia.
Brainstem or medial longitudinal fasciculus lesion
Sensory or motor symptoms on one side of the body or all 4 limbs
Bilateral facial numbness
Decreased consciousness or locked-in syndrome
Vertigo or tinnitus
Dysarthria or dysphagia
Nausea or vomiting
Diplopia, dysconjugate gaze, or gaze palsy
Hiccups, abnormal respirations
Lacunar involvement
Pure motor deficit
Pure sensory deficit
Dysarthria-clumsy hand syndrome
Ataxia or hemiplegia syndrome

Central spinal cord syndrome is typically indicated by cervical involvement accompanied by weakness and paresthesias in the hands and arms and, to a lesser extent, in the legs.
Anterior spinal cord syndrome is indicated by weakness or paralysis and loss of pain and temperature sensation below the level of the lesion, but with preserved proprioception.
Brown-Sequard syndrome (hemicord syndrome) is indicated by ipsilateral weakness and loss of proprioception, along with contralateral loss of pain and temperature sense below the level of the lesion.

Important Central Causes

Ischemia or hemorrhage. Face, neck, or chest pain may be associated with neurologic symptoms; a partial Horner syndrome may occur with carotid artery dissection.
Todd paralysis. A preceding seizure may or may not be clear from the patient’s medical history.
Infection (meningitis, encephalitis, myelitis). Causes may include spinal epidural abscess, and fever may or may not be present.
Space-occupying lesions. Such lesions can themselves cause acute symptoms, but sometimes the symptoms are caused by associated acute vasogenic edema or hemorrhage.
Hemiplegic migraine. Headache may or may not be present. New motor aura should be treated as a diagnosis of exclusion when stroke is plausible, especially at a first presentation.
Inflammatory, noninfectious encephalitis or myelitis may occur with systemic autoimmune or demyelinating disease.
Post-traumatic neurologic deficit may be due to direct neuronal injury or compression, hemorrhage, hematoma, edema, hydrocephalus, or secondary ischemia.
Spontaneous intracranial or spinal hemorrhage should be considered in patients taking anticoagulants, with coagulopathy, severe hypertension, vascular lesions, or suggestive acute symptoms.
Multiple sclerosis or other demyelinating disease may cause focal deficits, but first-time or rapidly progressive deficits still require exclusion of stroke and other emergencies.

Peripheral Nervous System

Although radiculopathies and more peripheral nerve disorders may include weakness, sensory changes, or both, identification of the distribution of such symptoms usually helps to localize the site of the abnormality.

With motor involvement, normal Babinski reflexes, absence of clonus, and decreased or normal deep tendon reflexes support a peripheral localization; however, early central lesions may not yet demonstrate classic upper motor neuron findings.

Table 2. Common Peripheral Motor Patterns

Neuropathy	Typical motor finding
Bell palsy (facial nerve)	Unilateral facial palsy that equally involves the forehead and lower face
Abducens palsy (cranial nerve VI)	Inability to abduct the eye on the affected side
Carpal tunnel (median nerve) syndrome	Weakness of thumb opposition and abduction
Cubital tunnel/Guyon canal (ulnar nerve) syndrome	Weakness of hand grip and pinch between thumb and index finger
Radial nerve palsy	Weakness of wrist and finger extension; reduced forearm supination
Brachial plexopathy	Variable shoulder and proximal arm weakness
Peroneal neuropathy	Weakness in ankle dorsiflexion and eversion, including hallux dorsiflexion

Other Causes of Acute Weakness

Other toxicologic, inflammatory, motor endplate, and idiopathic disorders can cause acute weakness, which may masquerade as a central or peripheral neurologic problem.

Guillain-Barre syndrome (GBS): ascending weakness accompanied by decreased reflexes. Cranial nerve involvement, autonomic dysfunction, and respiratory insufficiency can occur. Progressive weakness, bulbar symptoms, dyspnea, or impaired ambulation warrant hospital evaluation.
Miller-Fisher variant of GBS: initial symptoms involve cranial nerve deficits such as ophthalmoplegia and ataxia, often with reduced reflexes.
Myasthenia gravis: eyelid ptosis and weakness of extraocular muscles may be more noticeable than limb weakness. Progressive fatigue with sustained or repeated exercise decreases with rest. Bulbar or respiratory symptoms raise concern for myasthenic crisis and require emergency evaluation.
Lambert-Eaton myasthenic syndrome: limb and trunk weakness may transiently improve with sustained or repeated exercise.
Botulism: diplopia, dysarthria, dysphagia, autonomic symptoms, and descending paralysis may occur; obtain an exposure and food history.
Organophosphate poisoning: weakness may be associated with a cholinergic toxidrome and a history of pesticide exposure.
Tick paralysis: initial gait difficulty followed by ascending paralysis is characteristic.
Electrolyte abnormalities such as hypo- or hyperkalemia, hypo- or hypercalcemia, or hypo- or hypermagnesemia may cause weakness.
Primary myopathies usually produce symmetric proximal weakness and are less likely to create a true focal deficit.

Testing, Diagnosis, Treatment, and Disposition Pearls

Obtain a fingerstick blood glucose for patients with acute focal neurologic deficit at triage to avoid delays in appropriate treatment and help refine the differential diagnosis.
All patients with possible acute stroke require immediate EMS transport to an appropriate stroke-capable emergency department.
Brain and vascular imaging belong in the stroke pathway. Noncontrast head CT remains a rapid method to identify hemorrhage; CTA head and neck are commonly used to identify large-vessel occlusion, while MRI is more sensitive for small infarcts and selected posterior circulation or uncertain presentations.
For patients otherwise eligible for thrombolysis within 4.5 hours, advanced multimodal imaging should not delay treatment unnecessarily. Extended-window treatment decisions depend on receiving-facility imaging and stroke expertise.
Supplemental oxygen is not routinely needed in a nonhypoxemic stroke patient. Provide airway support, ventilatory assistance, and oxygen when clinically indicated.
Do not attempt aggressive blood pressure reduction in urgent care solely because stroke is suspected. Excessive lowering can worsen cerebral ischemia; urgent blood pressure treatment is reserved for separate emergencies or receiving-facility reperfusion protocols.
Do not give empiric aspirin or anticoagulation before hemorrhage is excluded and reperfusion decisions are made. Antiplatelet or anticoagulant treatment for TIA/minor stroke should be started within a coordinated stroke pathway after appropriate imaging and etiologic assessment.
New or resolved focal symptoms consistent with TIA require rapid evaluation. A normal neurologic examination after symptom resolution does not make the event benign.
TIA is now defined by transient focal neurologic symptoms without acute infarction on imaging. MRI with diffusion-weighted imaging and vascular imaging are important components of contemporary evaluation when available.
Patients with acute focal deficits localizing to the spinal cord generally require emergency transfer for MRI and specialist assessment. New weakness with a sensory level, bowel/bladder dysfunction, saddle anesthesia, severe back/neck pain, or rapidly progressive symptoms should not be managed expectantly in urgent care.
Patients with a clearly localized peripheral neuropathy may be managed as outpatients when onset is not progressive, there are no central or systemic red flags, function is preserved, and reliable follow-up is available.

Table 3. Urgent Care Disposition

Disposition	Typical criteria
EMS / emergency department	Suspected stroke or TIA; disabling or progressive focal deficit; central neurologic signs; acute spinal cord syndrome; severe headache/neck pain with focal findings; seizure with persistent deficit; suspected hemorrhage, infection, or toxicologic emergency; bulbar or respiratory weakness.
Urgent specialty / ED depending on severity	New cranial neuropathy with atypical features; progressive peripheral weakness; suspected demyelinating disease; new myelopathy; persistent unexplained focal deficit despite nondiagnostic initial assessment.
Outpatient management	Clearly peripheral, stable, nonprogressive mononeuropathy or radiculopathy with preserved function, no central red flags, and reliable follow-up.

Medicolegal Pearls

Immediately refer any patient with new focal neurologic deficits to the closest appropriate emergency department for further evaluation.
Patients with vertigo or headache and any lateralizing signs need emergency evaluation.
Document last known well, symptom-discovery time, the neurologic examination, glucose result, medication/anticoagulant history, and the rationale for transport destination.
Do not use symptom improvement in the clinic as reassurance against TIA or stroke. Document any resolution and still arrange urgent stroke evaluation when the history is compatible.
If a patient with suspected stroke or TIA refuses EMS transport, document the discussion of time-sensitive treatment options and potential consequences of delay, assess decision-making capacity, and provide the safest alternative plan possible.

References

Prabhakaran S, Gonzalez NR, Zachrison KS, et al. 2026 guideline for the early management of patients with acute ischemic stroke: a guideline from the American Heart Association/American Stroke Association. Stroke. 2026. doi:10.1161/STR.0000000000000513.
Amin HP, Madsen TE, Bravata DM, et al. Diagnosis, workup, risk reduction of transient ischemic attack in the emergency department setting: a scientific statement from the American Heart Association. Stroke. 2023;54:e109-e121. doi:10.1161/STR.0000000000000418.
American College of Radiology. ACR Appropriateness Criteria: Cerebrovascular Diseases-Stroke and Stroke-Related Conditions. Current online edition, 2026.
American College of Radiology. ACR Appropriateness Criteria: Myelopathy. Current online edition, 2026.
van Doorn PA, Van den Bergh PYK, Hadden RDM, et al. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of Guillain-Barre syndrome. Eur J Neurol. 2023;30(12):3646-3674. doi:10.1111/ene.16073.
Narayanaswami P, Sanders DB, Wolfe G, et al. International consensus guidance for management of myasthenia gravis: 2020 update. Neurology. 2021;96(3):114-122. doi:10.1212/WNL.0000000000011124.
Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition (ICHD-3). Cephalalgia. 2018;38(1):1-211.